Table 5 27 and 9 genes differentially expressed between primary and HR, and between primary and HS LuCaP 23.1 xenografts.
From: FGFR1 and WT1 are markers of human prostate cancer progression
HR vs LUCAP 23.1 | Description |
|---|---|
FGFR1 | Fibroblast growth factor receptor 1 |
KRT19 | Cytokeratin 19 |
CDK4 | Cyclin-dependent kinase 4 |
AMFR | Autocrine motility factor receptor |
VEGFR1 | Vegf receptor 1/FLT1 |
ITGA3 | Integrin alpha 3/CD49C |
MUC1 | Polymorphic epithelial mucin |
GRB7 | GRB7 adaptor |
RELA | NFKb, p65 subunit |
BCL3 | BCL3 protein |
SRF | Serum response factor |
MAX | MAX transcription regulator |
NEO1 | Neogenin homolog 1 |
ITGB5 | Integrin beta 5 |
RXRA | Retinoic X receptor alpha |
IGFBP4 | Insulin-like growth factor binding protein |
CASP9 | Caspase 9 |
CREBBP | CREB binding protein |
MMP15 | Membrane-type matrix metalloproteinase 2 |
SMAD9 | MAD homolog 9 |
BAK | Apoptosis regulator bak |
MMP9 | 92 kDa gelatinase, matrix metalloproteinase-9 |
GATA1 | GATA-binding protein 1 |
MRP5 | ATP-binding cassette, sub-family C, member 5 |
PPP2R2C | PP2A BR gamma |
EPOR | Erythropoietin receptor |
FZD5 | Frizzled 5, WNT pathway |
HS vs LuCaP 23.1 | |
MART1 | Melan-a protein |
CSTB | Cystatin b |
NR1H3 | Nuclear receptor liver X receptor |
VINC | Vinculin |
STMN1 | Stathmin, phosphoprotein p19 |
STAT1 | signal transducer and activator of transcription 1 |
CBLB | Cas-Br-M ectropic retroviral transforming sequence b |
WNT2 | WNT factor 2 |
CDH12 | Cadherin 12 |